Bank of America Corp DE bought a new position in shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 394,465 shares of the company's stock, valued at approximately $2,241,000. Bank of America Corp DE owned approximately 0.94% of Senseonics Holdings, Inc. Common Stock at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. The Manufacturers Life Insurance Company acquired a new position in Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at about $65,000. Tocqueville Asset Management L.P. acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth about $315,000. BlackRock Inc. purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $15,867,000. Deutsche Bank AG purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $223,000. Finally, State of Wyoming acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $67,000. 12.36% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on SENS. Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock from a "strong sell" rating to a "sell" rating in a report on Saturday, August 8th. Weiss Ratings upgraded Senseonics Holdings, Inc. Common Stock from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Thursday, September 17th. Finally, Mizuho lowered their target price on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an "outperform" rating for the company in a research note on Wednesday, July 15th. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Senseonics Holdings, Inc. Common Stock has a consensus rating of "Moderate Buy" and an average target price of $17.20.
Get Our Latest Stock Analysis on SENS
Insider Buying and Selling
In other news, Director Douglas Roeder acquired 13,953 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction on Wednesday, August 19th. The stock was bought at an average price of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the purchase, the director owned 171,191 shares in the company, valued at $1,537,295.18. This represents a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 4.70% of the stock is currently owned by company insiders.
Senseonics Holdings, Inc. Common Stock Trading Up 1.2%
SENS opened at $10.17 on Thursday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 6.40 and a current ratio of 6.74. Senseonics Holdings, Inc. Common Stock has a one year low of $4.79 and a one year high of $11.58. The company has a market cap of $425.11 million, a P/E ratio of -4.56 and a beta of 1.08. The business's 50-day simple moving average is $8.24 and its 200-day simple moving average is $6.95.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.08). The company had revenue of $14.48 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. As a group, equities research analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.29 EPS for the current fiscal year.
Senseonics Holdings, Inc. Common Stock Profile
(
Free Report)
Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing continuous glucose monitoring (CGM) systems for people with diabetes. Its technology is designed to measure glucose levels continuously and provide readings through a wearable transmitter and mobile application, supporting diabetes management and treatment decisions.
The company's principal product is the Eversense CGM system, which uses a small sensor implanted under the skin, a removable smart transmitter worn over the sensor, and a smartphone application.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Senseonics Holdings, Inc. Common Stock, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Senseonics Holdings, Inc. Common Stock wasn't on the list.
While Senseonics Holdings, Inc. Common Stock currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.